WTB RSS
05-14-2010, 08:59 AM
BioSante Pharmaceuticals said Friday its first-quarter loss widened on higher development costs for its drug candidate LibiGel.
More... (http://finance.yahoo.com/news/BioSante-1Q-loss-widens-on-apf-1405374668.html?x=0)
More... (http://finance.yahoo.com/news/BioSante-1Q-loss-widens-on-apf-1405374668.html?x=0)